TLP
Tri Locum Partners’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-176,109
| Closed | -$7.85M | – | 55 |
|
2022
Q4 | $7.85M | Sell |
176,109
-62,460
| -26% | -$2.78M | 3.17% | 11 |
|
2022
Q3 | $6.71M | Buy |
238,569
+106,421
| +81% | +$2.99M | 1.84% | 20 |
|
2022
Q2 | $3.56M | Sell |
132,148
-251,171
| -66% | -$6.77M | 1.46% | 22 |
|
2022
Q1 | $13.1M | Buy |
+383,319
| New | +$13.1M | 5.1% | 5 |
|
2021
Q3 | – | Sell |
-175,305
| Closed | -$5.86M | – | 28 |
|
2021
Q2 | $5.86M | Sell |
175,305
-21,367
| -11% | -$714K | 1.92% | 13 |
|
2021
Q1 | $4.05M | Buy |
+196,672
| New | +$4.05M | 1% | 18 |
|